Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
testosterone
|
| gptkbp:approvedBy |
gptkb:FDA
2000 |
| gptkbp:ATCCode |
G03BA03
|
| gptkbp:contraindication |
gptkb:cancer
prostate cancer pregnancy |
| gptkbp:form |
gel
|
| gptkbp:genericAvailable |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
AndroGel
|
| gptkbp:indication |
male hypogonadism
|
| gptkbp:launchSite |
abdomen
shoulders upper arms |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:AbbVie
|
| gptkbp:pregnancyCategory |
X
|
| gptkbp:prescriptionRequired |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021015s040lbl.pdf
|
| gptkbp:riskFactor |
secondary exposure to others
|
| gptkbp:routeOfAdministration |
topical
|
| gptkbp:sideEffect |
hair loss
acne mood changes skin irritation increased red blood cell count |
| gptkbp:usedFor |
testosterone replacement therapy
|
| gptkbp:bfsParent |
gptkb:Testogel
|
| gptkbp:bfsLayer |
7
|